Brian A. Leuthner, President and CEO at Edge Therapeutics, Inc. (EDGE), sold 7,500 shares at $9.97 ($74K) on 2017-12-04, disclosed to the SEC on 2017-12-05.
Scheduled sale ($74k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.92 | 2,500 | $25K | 33.5% |
| 2 | $9.97 | 2,500 | $25K | 33.7% |
| 3 | $9.68 | 2,500 | $24K | 32.7% |
| Total | $9.86 avg | 7,500 | $74K | 100% |
| Filing → |
| EDGE | SELL | 2018-02-23 | $77K | — | Filing → |
| EDGE | SELL | 2018-02-02 | $65K | — | Filing → |
| EDGE | SELL | 2018-01-03 | $51K | — | Filing → |